🔗 Share this article Patients Coming Off Weight-Loss Injections Gain Back Weight at a Quadrupled Rate Than Those on Conventional Diets Obesity treatment involves ongoing approaches. New research indicates that individuals who come off new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who end conventional lifestyle plans. Published data in a leading health publication shows that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit. "People using such treatments should be informed of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb. This pace of recovery implies a reversion to original mass within about one and a half years. Analyzing Approaches The analysis, which examined 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting. Scientists point out that individuals who lose weight through dieting typically have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention. The Reason for the Fast Regain Doctors suggest the mechanism of the injections is key to understanding the accelerated weight return. GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness. "Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist. "Withdrawal of this hormone supplement means appetite is uncontrolled, making binge eating far more likely." A Chronic Disease? Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes. A number of clinicians say that, considering the high risk of relapse, the treatment should be considered life-long. This view is supported by drug manufacturers, who note that the results "emphasize the persistent nature of excess weight," comparing it to managing diseases like diabetes. Patient Accounts People who have come off the medication describe a powerful resurgence of hunger. "It felt as if something that goes on and you become extremely hungry," described an individual. The struggle is worsened if patients have not established sustainable dietary or behavioural modifications during treatment. Significant Adoption Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with interest continuing to grow. Adoption is more common among women compared to males. The middle-aged demographic shows the greatest usage rates. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, researchers caution that while the jabs are potent agents for weight loss, they are not a standalone fix and long-term success hinges on ongoing lifestyle management.
Obesity treatment involves ongoing approaches. New research indicates that individuals who come off new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who end conventional lifestyle plans. Published data in a leading health publication shows that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit. "People using such treatments should be informed of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb. This pace of recovery implies a reversion to original mass within about one and a half years. Analyzing Approaches The analysis, which examined 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting. Scientists point out that individuals who lose weight through dieting typically have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention. The Reason for the Fast Regain Doctors suggest the mechanism of the injections is key to understanding the accelerated weight return. GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness. "Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist. "Withdrawal of this hormone supplement means appetite is uncontrolled, making binge eating far more likely." A Chronic Disease? Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes. A number of clinicians say that, considering the high risk of relapse, the treatment should be considered life-long. This view is supported by drug manufacturers, who note that the results "emphasize the persistent nature of excess weight," comparing it to managing diseases like diabetes. Patient Accounts People who have come off the medication describe a powerful resurgence of hunger. "It felt as if something that goes on and you become extremely hungry," described an individual. The struggle is worsened if patients have not established sustainable dietary or behavioural modifications during treatment. Significant Adoption Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with interest continuing to grow. Adoption is more common among women compared to males. The middle-aged demographic shows the greatest usage rates. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, researchers caution that while the jabs are potent agents for weight loss, they are not a standalone fix and long-term success hinges on ongoing lifestyle management.